Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center

BACKGROUND: Several plasma volume expander alternatives exist to enhance intravascular volume status in patients undergoing surgery. The optimal intravascular volume expander in the perioperative setting is currently unknown. Low molecular weight hetastarch, Voluven® (130/0.4), may have a better saf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Perioper Med (Lond)
Autori principali: Bartz, Raquel R, White, William D, Gan, Tong J
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349603/
https://ncbi.nlm.nih.gov/pubmed/25741439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13741-015-0013-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi